What price pain relief?
Hochman
Judith S
JS
Shah
Nirav R
NR
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D001241:Aspirin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000401:mortality; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D017277:Drug Approval; D004359:Drug Therapy, Combination; D011464:Epoprostenol / Q000502:physiology; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D009203:Myocardial Infarction; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology; D010974:Platelet Aggregation / Q000187:drug effects; D054328:Proton Pump Inhibitors; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D054328:Proton Pump Inhibitors; D011464:Epoprostenol; D001241:Aspirin